Combined effect of CDDP and caffeine against human gastric cell line in vivo

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4399-4401

  Takahashi, Makoto ^a   Yanoma, Syunnsuke ^b   Yamamotq, Yuji ^a   Rino, Yasushi ^a   Amano, Tomishige ^a   Imada, Toshio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Kanagawa Cancer Research Center   (Japan)

Author keywords

Caffeine; CDDP; Gastric cancer; Peritoneal dissemination

Indexed keywords

ANTINEOPLASTIC AGENT; CAFFEINE; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; STOMACH CANCER;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAFFEINE; CISPLATIN; FEMALE; HUMANS; MICE; MICE, NUDE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032442707     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kano T, Kumashiro S, Masuda H, et al: Recurrent gastric carcinoma: Analysis of 100 inpatients. Jpn J Surg 13: 106-111, 1983.
2. Howell SB, Pfeile CL, Wung WE et al: Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845-851, 1982.
3. Meer M, et al: A phase II study of cisplatin in advanced gastric cancer. Eur. J Clin Oncol 19: 717-720, 1983.
4. Takahashi M, Yamamoto Y, Hatori S et al: Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death. Oncology Rep 5: 53-56, 1998.
5. Rosenberg B, Van Camp L, Trosko JE et al: Platinum compounds; a new class of potent anti-tumor agents. Nature 222: 385-386, 1969.
6. Leichman L et al: Cisplatin. an active drug in the treatment of disseminated gastric cancer. Cancer 53: 18-22, 1984.
7. Imada T, Rino Y, Takahashi M et al: In vitro combination effect of 5-fluorouracil and cisplatin on the proliferation, morphology and expression of Ki-67 antigen in human gastric cancer cells. Anticancer Drugs 8: 1000-1006, 1997.
8. Sims JL, Sikorski GW, Cantino DM, Berger SJ, Berger NA: Poly (adenosinediphosphoribose) polymerase inhibitors stimulate unsche-duled deoxyribonucleic acid synthesis in normal human lymphocytes. Biochemistry 21: 1813-1821, 1982.
9. Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ: Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal factor receptor. Cancer Res 52: 4758-4765, 1992.
10. Mourelatos D, Dozi-Vassiliades J, Kotsis A, Gourtsas C.: Enhancement of cytogenetic and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo. Cancer Res 48: 1129-1131, 1988.
11. Yamamoto Y, Amano T, Imada T et al: Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis. J Jpn Cancer Chemother 18: 1825-1831, 1991.
12. Ogasawara H, Nishio K, Ishida T, et al: In vitro enhancement of antitumor activity of a water-soluble Duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells. Jpn J Cancer Res 88: 1033-1037, 1997.
13. Yasutake H, Tsuchiya H, Tomita K, Matsunaga T, Nikatdo O, Mori T: Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated .human osteosarcoma. Anticancer Res 15: 831-837, 1995.